Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor.

Helmstädter, Johanna; Keppeler, Karin; Küster, Leonie; Münzel, Thomas; Daiber, Andreas; Steven, Sebastian

Helmstädter, Johanna; Keppeler, Karin; Küster, Leonie; Münzel, Thomas; Daiber, Andreas; Steven, Sebastian.

Afiliação

Helmstädter J; Department of Cardiology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Keppeler K; Department of Cardiology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Küster L; Department of Cardiology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Münzel T; Department of Cardiology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
Daiber A; Center of Thrombosis and Hemostasis (CTH), University Medical Center, Mainz, Germany.
Steven S; Partner Site Rhine-Main, German Center for Cardiovascular Research (DZHK), Mainz, Germany.

Br J Pharmacol ; 179(4): 659-676, 2022 02.

Article em En | MEDLINE | ID: mdl-33764504

Assuntos

Doenças Cardiovasculares; Sistema Cardiovascular; Diabetes Mellitus Tipo 2; Doenças Cardiovasculares/prevenção & controle; Diabetes Mellitus Tipo 2/metabolismo; Peptídeo 1 Semelhante ao Glucagon/metabolismo; Receptor do Peptídeo Semelhante ao Glucagon 1/agonistas; Humanos; Hipoglicemiantes/farmacologia; Hipoglicemiantes/uso terapêutico

Palavras-chave

GLP-1 metabolites; cardiovascular outcome trial; cardiovascular protection; diabetes mellitus; glucagon-like peptide-1 receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Sistema Cardiovascular / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google